HARBOUR BIOMED Growth, Revenue, Number of Employees and Funding

Overview

Location:
Pudong New Area, China
Total Funding:$135M
Industry:Biotech
Founded:2016
Lead Investor(s):GIC Private Limited,
Press

Industry Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • HARBOUR BIOMED's estimated revenue is currently $10.9M per year.
  • HARBOUR BIOMED received $85.0M in venture funding in August 2018.
  • HARBOUR BIOMED's estimated revenue per employee is $144667
  • HARBOUR BIOMED's total funding is $135M.

Employee Data

  • HARBOUR BIOMED has 75 Employees.
  • HARBOUR BIOMED grew their employee count by 14% last year.
  • HARBOUR BIOMED currently has 1 job openings.

Executive Contacts

NameTitle
Timothy MillerAssociate Director of Business Development and Alliances
Michael LeeSenior Director
Shuyi TangAssociate Director
Atul Deshpande Ph.D.Chief Strategy Officer & Head, US Operations
Xiaoxiang ChenChief Development Officer
Mai-Jing LiaoChief Business Officer
George LiuVP/Head of Early Development and Scientific Operation
Atul DeshpandeChief Strategy Officer and Head of U.S. Operations
Frank GrosveldFounding Chief Scientific Officer

What Is HARBOUR BIOMED?

Harbour BioMed is a global biotechnology company discovering and developing innovative therapeutics for cancer with a focus on immuno-oncology. The company's discovery and development programs are centered around its two patented transgenic mouse platforms for human antibody discovery. The company is building its proprietary pipeline internally, through collaborations with co-development partners, and selective preclinical and clinical stage asset acquisitions. Harbour BioMed also licenses the platforms to companies and academic institutions through its Harbour Antibodies subsidiary. Learn more about Harbour Biomed: www.harbourbiomed.com/

keywords:N/A

75

Number of Employees

$10.9M

Revenue (est)

1

Current Jobs

14%

Employee Growth %

$135M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
HARBOUR BIOMED
$10.9M7514%$135M

HARBOUR BIOMED News

4-Jan-19 - Harbour BioMed Appoints Atul Deshpande, Ph.D. MBA, Chief Strategy

CAMBRIDGE, Mass. & SHANGHAI & ROTTERDAM, Netherlands--(BUSINESS WIRE)--Harbour BioMed announced the appointment of Atul

13-Mar-19 - LabShares Celebrates Grand Opening and Unveils Newly Expanded

Members include: AffyImmune Therapeutics, Abcuro Inc., ArrowDots BioMedicals, Extend Biosciences, Harbour Biomed, Siamab Therapeutics,

26-Aug-18 - Harbour BioMed Raises $85 Million in Series B Financing to

SHANGHAI & ROTTERDAM, The Netherlands & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Harbour BioMed announced today that it has

HARBOUR BIOMED Funding

DateAmountRoundLead InvestorsReference
2018-01-23$UndisclosedA+CDH InvestmentsArticle
2018-08-27$85.0MBGIC Private Limited,Article

HARBOUR BIOMED Executive Hires

DateNameTitleReference
2019-01-07Atul DeshpandeChief Strategy Officer and Head of U.S. OperationsArticle